Olympus Future Growth

Future criteria checks 3/6

Olympus is forecast to grow earnings and revenue by 14.4% and 5.1% per annum respectively. EPS is expected to grow by 16% per annum. Return on equity is forecast to be 16.1% in 3 years.

Key information

14.4%

Earnings growth rate

16.0%

EPS growth rate

Medical Equipment earnings growth12.6%
Revenue growth rate5.1%
Future return on equity16.1%
Analyst coverage

Good

Last updated15 Nov 2024

Recent future growth updates

Recent updates

Olympus' (TSE:7733) Strong Earnings Are Of Good Quality

Nov 15
Olympus' (TSE:7733) Strong Earnings Are Of Good Quality

Olympus Corporation's (TSE:7733) Share Price Could Signal Some Risk

Nov 07
Olympus Corporation's (TSE:7733) Share Price Could Signal Some Risk

Olympus (TSE:7733) Hasn't Managed To Accelerate Its Returns

Oct 12
Olympus (TSE:7733) Hasn't Managed To Accelerate Its Returns

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Sep 27
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Does Olympus (TSE:7733) Have A Healthy Balance Sheet?

Jul 14
Does Olympus (TSE:7733) Have A Healthy Balance Sheet?

Estimating The Fair Value Of Olympus Corporation (TSE:7733)

Jun 28
Estimating The Fair Value Of Olympus Corporation (TSE:7733)

Slowing Rates Of Return At Olympus (TSE:7733) Leave Little Room For Excitement

Mar 28
Slowing Rates Of Return At Olympus (TSE:7733) Leave Little Room For Excitement

Olympus Corporation's (TSE:7733) Share Price Matching Investor Opinion

Mar 13
Olympus Corporation's (TSE:7733) Share Price Matching Investor Opinion

Earnings and Revenue Growth Forecasts

TSE:7733 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20271,117,050158,643115,326207,81113
3/31/20261,055,588142,517106,331192,77114
3/31/20251,003,968117,52971,114173,48614
9/30/2024973,59587,72681,759147,854N/A
6/30/2024966,04627,88456,269118,734N/A
3/31/2024936,21026,610-22,25942,365N/A
12/31/2023916,09239,468-36,58330,686N/A
9/30/2023901,50756,53411,19580,406N/A
6/30/2023875,586126,381-1,68072,238N/A
3/31/2023881,923137,80927,86798,490N/A
12/31/2022933,645137,62345,131109,416N/A
9/30/2022925,858126,84847,185107,203N/A
6/30/2022891,410121,91260,183119,188N/A
3/31/2022868,867115,742107,958169,729N/A
12/31/2021793,72795,27485,693150,356N/A
9/30/2021774,11398,06390,544155,506N/A
6/30/2021785,41184,46778,484139,415N/A
3/31/2021730,54465,59964,895124,122N/A
12/31/2020715,92446,44355,563116,827N/A
9/30/2020724,72241,45942,698103,723N/A
6/30/2020752,17642,85550,303113,526N/A
3/31/2020797,41151,67067,615133,544N/A
12/31/2019807,88760,75872,843136,095N/A
9/30/2019801,20249,70444,493106,769N/A
6/30/2019795,19333,4698,58670,321N/A
3/31/2019793,8628,1475,47766,943N/A
12/31/2018795,47915,5549,62371,514N/A
9/30/2018798,91521,73215,84379,978N/A
6/30/2018795,20530,324N/A100,036N/A
3/31/2018786,49757,064N/A95,146N/A
12/31/2017786,60885,083N/AN/AN/A
9/30/2017767,50885,830N/A91,430N/A
6/30/2017751,45879,716N/AN/AN/A
3/31/2017748,05078,191N/A90,194N/A
12/31/2016745,54360,888N/AN/AN/A
9/30/2016758,77748,983N/A35,146N/A
6/30/2016785,44454,390N/AN/AN/A
3/31/2016804,57862,594N/A48,621N/A
12/31/2015807,1972,188N/AN/AN/A
9/30/2015805,4324,742N/A92,093N/A
6/30/2015785,230-144N/AN/AN/A
3/31/2015764,671-8,737N/A66,811N/A
12/31/2014749,62739,710N/AN/AN/A
9/30/2014734,46943,896N/A72,544N/A
6/30/2014721,07023,599N/AN/AN/A
3/31/2014713,28613,627N/A72,388N/A
12/31/2013696,2976,239N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7733's forecast earnings growth (14.4% per year) is above the savings rate (0.3%).

Earnings vs Market: 7733's earnings (14.4% per year) are forecast to grow faster than the JP market (8% per year).

High Growth Earnings: 7733's earnings are forecast to grow, but not significantly.

Revenue vs Market: 7733's revenue (5.1% per year) is forecast to grow faster than the JP market (4.2% per year).

High Growth Revenue: 7733's revenue (5.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 7733's Return on Equity is forecast to be low in 3 years time (16.1%).


Discover growth companies